‌

US Patent 7345153 Compounds capable of inhibiting HIV-1 infection

Patent 7345153 was granted and assigned to Progenics Pharmaceuticals on March, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Progenics Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

73451530

Patent Inventor Names

Graham P. Allaway0

Virginia M. Litwin0

Paul J. Maddon0

Date of Patent

March 18, 2008

Patent Application Number

115443460

Date Filed

October 5, 2006

Patent Primary Examiner

‌

Jeffrey S. Parkin

Patent abstract

This invention provides an antibody capable of specifically inhibiting the fusion of an HIV-1 envelope glycoprotein+ cell with an appropriate CD4+ cell without cross reacting with the HIV-1 envelope glycoprotein or CD4 and capable of inhibiting infection by one or more strains of HIV-1. This antibody is then used to identify a molecule which is important for HIV infection. Different uses of the antibody and the molecule are described.